Appendix 4D and Half Year Financial Report
Filed with ASX · · 24 pages · English
These accounts have been subject to review and there has been no qualification or dispute. Explanation of the above information: Refer to the Directors' Report - Review of Operations. Approved Date: 27 February 2026 Consolidated Financial Statements Contents Consolidated Financial Statements Directors' Report Page 1 Auditor's Independence Declaration under Section 307C of the Corporations Act 2001
Vitasora Health Limited on 6ix
Story so far
Earlier from Vitasora Health
- Appendix 4C and Quarterly Activities Report
- Completion of A$11m Raise and Cornerstone Investment
- Quarterly Activities/Appendix 4C Cash Flow Report
- Vitasora Expands U.S. Partnership with Evolent
- Vitasora Cornerstone Investor Placement Update
Later from Vitasora Health
- Vitasora Execute vCare Rollout - Revenue Scaling Accelerates
- VHL Raises $4m Cornerstoned by $3m Strategic Investment
- June 2026 Appendix 4E
- Vitasora Market Update Presentation - October 2026
- Notice of Annual General Meeting/Proxy Form
Follow Vitasora Health into a list and get an email when it puts out news.
Follow Vitasora Health